Turbidimetric immunoassay for assessing human Cystatin C

a technology of immunoassay and cystatin, which is applied in the field of tumorimetric immunoassay for assessing human cystatin c, can solve the problems of unsuccessful prior art products, and achieve the effects of high affinity (or avidity), strong signal to noise ratio, and high aggregation signal

Active Publication Date: 2012-09-11
GENTIAN AS
View PDF12 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0036]By careful adjustments of immunoparticles and optionally assay reagents, a surprisingly stronger and faster turbidimetric signal could be observed, and thereby interferences could be reduced and the linearity could be improved without loosing accuracy. Also the assay time could be reduced.
[0047]The “accuracy” of an analytical method of the present invention, is the methods ability to accurately determine the concentration of Cystatin C in a sample, compared to the concentration as determined by an even more reliable reference method.

Problems solved by technology

However said prior art products turned out to be unsuccessful.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Turbidimetric immunoassay for assessing human Cystatin C
  • Turbidimetric immunoassay for assessing human Cystatin C
  • Turbidimetric immunoassay for assessing human Cystatin C

Examples

Experimental program
Comparison scheme
Effect test

synthesis example 1

Preparation of Polyclonal Avian Serum and Affinity Purification thereof

a) Preparation of Avian Serum

[0173]The following immunization protocol may be used for the generation of polyclonal IgY antibodies against human Cystatin C:

[0174]Two to four hens are used for each immunization experiment. A couple of eggs are collected before immunization begins. IgY purified from these eggs will serve as the control IgY. 100 μg of highly purified human Cystatin C (purified from urine of patients with tubular proteinuria) in phosphate buffer was emulsified with Freund's complete adjuvant and injected into the breast muscle of hens. The injection was repeated every 4 weeks. 10 weeks after the start of the injections, eggs were collected. The egg yolk was isolated from the eggs, and the IgY fraction from the egg yolk was isolated by ammoniumchloride precipitation, in a conventional manner according to prior art methods of egg antibody isolation (see for example Larsson A, Baaloew R-M, Lindahl T, an...

synthesis example 2

Preparation of Monoclonal Anti-Human Cystatin C Antibodies

[0177]The preparation of monoclonal anti-human Cystatin C antibodies may be performed as follows by making use of methods well known in the art, described for example by Harlow et al., 1988, Section 6 of “Antibodies: a Laboratory Manual”, Cold Spring Harbor Press, New York, USA. Human PSA was isolated from human seminal plasma as described Sensabaugh et al., 1990, J. Urology 144, 1523.

[0178]Mice were immunized in regular intervals with 4 injections of 50 μg human Cystatin C in RAS (RIBI adjuvant system). Four months after the first injection lymphocytes isolated from the spleen of the immunized mice were fused with the myeloma cell line SP2 / 0-Ag14 using the polyethyleneglycol method as described by G. Galfre et al., 1981, Methods in Enzymology, 73, 3-46.

[0179]Hybridomas secreting an antibody against Cystatin C were identified by the following screening ELISA: microtiterplates were coated with rabbit anti-human-Cystatin C immu...

synthesis example 3

Preparation of Anti-Cystatin C Immunoparticles

a) Coupling Process—Standard Procedure:

(1) Buffers & Reagents

[0183]

MES Buffer0.01 MpH 6Borate Buffer0.05 MpH 9.3PBS Buffer0.05 MpH 7.2Storage Buffer0.05 M TRISpH 8.4; 1 g / l glycine; 1 g / l2 g / l albumin, TWEEN® 201 g / l transferrinAntibodyAb of your choice at a concentration of1.0 mg / ml in MESUltraCleanAs supplied at 4% solids.Chloromethyl Latex

[0184]In order to have more signal from the polymer particles per mg of antibody the pH of coupling buffer was adapted in a specific way to the pi of the antibodies to be coupled. In addition the antibodies were diluted with albumin / transferrin prior to coupling (see below). For coupling a pH half a unit above the pi of the antibody was chosen when monoclonal antibodies were used. Polyclonal antibodies have a quite diverse pi, and so with polyclonal antibodies pH of 8.8 was used. The chosen pH was obtained by mixing the above mentioned PBS and borate buffers.

[0185]The following standard procedure out...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
median diameteraaaaaaaaaa
mean diameteraaaaaaaaaa
median diameteraaaaaaaaaa
Login to view more

Abstract

There is a demand for improved turbidimetric immunoassays for human Cystatin C in biological samples, especially in human clinical samples of body fluids. The present invention provides a turbidimetric immunoassay method and reagent set enabling measurement of human Cystatin C by turbidimetric methods, resulting in a surprisingly stronger and faster turbidimetric signal than in the present state of the art. The increased and faster signal is accomplished by the use of new reagents and compositions, and enables shorter assay times and kinetic reading with a stronger signal, improving overall assay speed and quality. Improved robustness to lipid interference and improved linearity is achieved.

Description

[0001]This application is the U.S. national phase, pursuant to 35 U.S.C. §371, of PCT international application Ser. No. PCT / Ib2006 / 004182, filed Nov. 24, 2006, designating the United States and published in English on Sep. 13, 2007 as publication WO 2007 / 102054 A3, which claims priority to Norwegian application Ser. No. 20055561, filed Nov. 24, 2005, Norwegian application Ser. No. 20055603, filed Nov. 28, 2005 and Norwegian application Ser. No. 20062288, filed May 19, 2006. The entire contents of the aforementioned patent applications are incorporated herein by this reference.[0002]The present invention relates to an improved turbidimetric immunoassay for assessing human Cystatin C in a human body liquid sample by making use of specific nanoparticle-antibody conjugates; a method for the assessment of the glomerular filtration rate of a patient by making use of said assay; corresponding reaction kits; improved nanoparticle-antibody conjugates and their use for the above mentioned me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): G01N33/543
CPCG01N33/54346G01N2800/347G01N2333/8139
Inventor SUNDE, KATHRINNILSEN, TOM
Owner GENTIAN AS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap